GLP-1 Medications for Weight Loss Now Available!

The state of Florida currently has 5 active clinical trials seeking participants for Weight Loss research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
NCT07104383
Recruiting
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: Viking Clinical Site #2013, Clearwater, Florida +12 locations
Conditions: Weight Loss
Register for Updates
VK2735 for Weight Management Phase 3
NCT07104500
Recruiting
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: Viking Clinical Site #1013, Clearwater, Florida +13 locations
Conditions: Weight Loss
Register for Updates
WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)
NCT06861790
Recruiting
The goal of the study to understand the effects of weight loss and improvements in diabetes following bariatric surgery on brain function and thinking. This study will also examine whether non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention initiated 30 days post-surgery improves brain function and thinking. The study does NOT cover any costs associated with bariatric surgery.
Gender:
ALL
Ages:
Between 20 years and 75 years
Trial Updated:
07/11/2025
Locations: University of Florida - College of Public Health and Health Professions, Gainesville, Florida
Conditions: Diabetes, Weight Loss
Register for Updates
A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications
NCT07012317
Recruiting
The objective of this study is to assess self-reported gastrointestinal (GI) responses to three snack bars containing fiber/fiber blends vs. a control snack bar for 7 days each in adults using GLP-1 agonists.
Gender:
ALL
Ages:
Between 25 years and 64 years
Trial Updated:
06/06/2025
Locations: Excellence Medical and Research, Miami Gardens, Florida +1 locations
Conditions: Gastrointestinal Symptoms, Weight Loss, GLP-1
Register for Updates
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
NCT06828055
Recruiting
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm dose-finding study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 Oral Formulation in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once daily.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2025
Locations: Viking Clinical Site #101, Clearwater, Florida +3 locations
Conditions: Weight Loss
Register for Updates